Article

Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis

2023-09-18

Abstract excerpt

<h4>ABSTRACT</h4> Malignant forms of breast cancer refractory to existing therapies remain a major unmet health issue, primarily due to metastatic spread. A better understanding of the mechanisms at play will provide better insights for alternative treatments to prevent breast cancer cells dispersion. Here, we identify the lysine methyltransferase SMYD2 as a clinically actionable master regulator of breast cancer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 72bbf306-72b0-55c6-bf15-f006117c416a
DOI: 10.1101/2023.09.18.558201

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasisDOI 10.1101/2023.09.18.558201Read

SMYD3 promotes the epithelial–mesenchymal transition in breast cancerSemantic proximity Read

YTHDF3 modulates the progression of breast cancer cells by regulating FGF2 through m6A methylationSemantic proximity Read

Unlocking the role of SH3PXD2B in epithelial-to-mesenchymal transition driving Breast Cancer Lung MetastasisSemantic proximity Read

The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancerSemantic proximity Read

Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation.Semantic proximity Read

mDia2 is an important mediator of MRTF-A-dependent regulation of breast cancer cell migrationSemantic proximity Read

Methyl-CpG binding domain protein 2 plays a causal role in breast cancer growth and metastasisSemantic proximity Read

KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challengesSemantic proximity Read

Perturbation of BRMS1 interactome reveals pathways that impact cell migrationSemantic proximity Read

ATIP3, a Novel Prognostic Marker of Breast Cancer Patient Survival, Limits Cancer Cell Migration and Slows Metastatic Progression by Regulating Microtubule DynamicsSemantic proximity Read

Metastatic function of METTL18 in breast cancer via actin methylation and SrcSemantic proximity Read

Microtubule deacetylation drives kinesin-1 mediated mitochondrial transport accelerating breast cancer cell migrationSemantic proximity Read